A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia
暂无分享,去创建一个
Z. Estrov | H. Kantarjian | G. Garcia-Manero | J. Cortes | S. Verstovsek | Xuelin Huang | T. Kadia | F. Ravandi | E. Jabbour | N. Daver | C. Dinardo | S. Kornblau | N. Pemmaraju | N. Jain | N. Short | G. Nogueras-Gonzalez | L. Masarová | Y. Alvarado | S. Pierce | P. Bose | K. Naqvi | S. Tse | Yvonne Gasior | J. Villareal